Mechanisms involved in the blunted nitric oxide–cGMP pathway in hypertensive TGR(mREN2)27 rats
- 5 March 2001
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 415 (1) , 27-30
- https://doi.org/10.1016/s0014-2999(01)00806-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Contribution of the renin–angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 ratsEuropean Journal of Pharmacology, 2000
- Studying the Structure and Regulation of Soluble Guanylyl CyclaseMethods, 1999
- Downregulation of Soluble Guanylyl Cyclase in Young and Aging Spontaneously Hypertensive RatsCirculation Research, 1999
- Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in ratsPharmaceutica Acta Helvetiae, 1998
- Circadian blood pressure variation in transgenic hypertensive rats.Hypertension, 1993
- PHARMFIT—a Nonlinear Fitting Program for PharmacologyChronobiology International, 1991
- Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 geneNature, 1990
- Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound hemeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- Activation of purified soluble guanylate cyclase by protoporphyrin IX.Proceedings of the National Academy of Sciences, 1982
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970